5-methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer?

por Belkhiri, Abbes, El-Rifai, Wael
Publicado 2013

Advances in targeted therapies and new promising targets in esophageal cancer

por Belkhiri, Abbes, El-Rifai, Wael
Publicado en Oncotarget (2015)

Therapeutic prospects for p73 and p63: Rising from the shadow of p53

por Vilgelm, Anna, El-Rifai, Wael, Zaika, Alexander
Publicado 2008

DARPP-32 Increases Interactions Between Epidermal Growth Factor Receptor and ERBB3 to Promote Tumor Resistance to Gefitinib

por Zhu, Shoumin, Belkhiri, Abbes, El-Rifai, Wael
Publicado 2011

DARPP-32: from neurotransmission to cancer

por Belkhiri, Abbes, Zhu, Shoumin, El-Rifai, Wael
Publicado en Oncotarget (2016)

The Aurora kinase A Regulates GSK-3β in Gastric Cancer Cells

por Dar, Altaf A, Belkhiri, Abbes, El-Rifai, Wael
Publicado 2008

Aurora kinase A in gastrointestinal cancers: time to target

por Katsha, Ahmed, Belkhiri, Abbes, Goff, Laura, El-Rifai, Wael
Publicado en Mol Cancer (2015)

The antioxidant response in Barrett's tumorigenesis: A double-edged sword

por Peng, Dunfa, Zaika, Alexander, Que, Jianwen, El-Rifai, Wael
Publicado en Redox Biol (2021)

Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?

por Khalafi, Shayan, Lockhart, Albert Craig, Livingstone, Alan S., El-Rifai, Wael
Publicado en Cancers (Basel) (2020)

DNA Copy Number Changes in Development and Progression in Leiomyosarcomas of Soft Tissues

por El-Rifai, Wa’el, Sarlomo-Rikala, Maarit, Knuutila, Sakari, Miettinen, Markku
Publicado 1998

ESOPHAGEAL ADENOCARCINOMA: TREATMENT MODALITIES IN THE ERA OF TARGETED THERAPY

por Mukherjee, Kaushik, Chakravarthy, A. Bapsi, Goff, Laura W., El-Rifai, Wael
Publicado 2010

Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells

por Vangamudi, Bhavatarini, Zhu, Shoumin, Soutto, Mohammed, Belkhiri, Abbes, El-Rifai, Wael
Publicado 2011

Resistance to TRAIL is mediated by DARPP-32 in gastric cancer

por Belkhiri, Abbes, Zhu, Shoumin, Chen, Zheng, Soutto, Mohammed, El-Rifai, Wael
Publicado 2012

AURKA regulates JAK2–STAT3 activity in human gastric and esophageal cancers

por Katsha, Ahmed, Arras, Janet, Soutto, Mohammed, Belkhiri, Abbes, El-Rifai, Wael
Publicado en Mol Oncol (2014)

Aurora Kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells

por Dar, Altaf A, Belkhiri, Abbes, Ecsedy, Jeffrey, Zaika, Alexander, El-Rifai, Wael
Publicado 2008

Role of Bacterial and Viral Pathogens in Gastric Carcinogenesis

por Palrasu, Manikandan, Zaika, Elena, El-Rifai, Wael, Que, Jianwen, Zaika, Alexander I.
Publicado en Cancers (Basel) (2021)

Aurora Kinases’ Inhibitors – Rising Stars in Cancer Therapeutics?

por Dar, Altaf A, Goff, Laura W., Majid, Shahana, Berlin, Jordan, El-Rifai, Wael
Publicado 2010

Regulation of ERBB2 Receptor by t-DARPP Mediates Trastuzumab Resistance in Human Esophageal Adenocarcinoma

por Hong, Jun, Katsha, Ahmed, Lu, Pengcheng, Shyr, Yu, Belkhiri, Abbes, El-Rifai, Wael
Publicado 2012

The Combination of Alisertib, an Investigational Aurora kinase A inhibitor, and Docetaxel Promotes Cell Death and Reduces Tumor Growth in Pre-Clinical Cell Models of Upper Gastroin...

por Sehdev, Vikas, Katsha, Ahmed, Ecsedy, Jeffrey, Zaika, Alexander, Belkhiri, Abbes, El-Rifai, Wael
Publicado 2012

Glutathione Peroxidase 7 Suppresses Bile Salt-Induced Expression of Pro-Inflammatory Cytokines in Barrett's Carcinogenesis

por Peng, Dun-Fa, Hu, Tian-Ling, Soutto, Mohammed, Belkhiri, Abbes, El-Rifai, Wael
Publicado 2014